Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine in newly diagnosed glioblastoma
NCT02432417Phase 2Withdrawn
- Sponsor
- Maastro Clinic
- Start
- Nov 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of chloroquine in glioblastoma (GBM), sponsored by Maastro Clinic. Planned start Nov 2023; status: withdrawn.
02
Drugs
chloroquine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02432417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432417.